BCLI
BCLI clinical trials: BRAINSTORM CELL THERAPEUTICS INC.
Every trial on ClinicalTrials.gov where BRAINSTORM CELL THERAPEUTICS INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 7
- Trials linked
- 7
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
BCLI on the catalyst calendar · BCLI registry changes
- Primary completion Nov 1, 2028Sponsor estimatePhase 3NCT06973629Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE...Brainstorm-Cell Therapeutics · Amyotrophic Lateral Sclerosis (ALS)Not yet recruitingBCLILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2016ActualPhase 2NCT02017912Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALSBrainstorm-Cell Therapeutics · Amyotrophic Lateral Sclerosis (ALS)CompletedBCLILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT04681118Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALSBrainstorm-Cell Therapeutics · Amyotrophic Lateral SclerosisNo longer availableBCLILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 29, 2020ActualPhase 3NCT03280056Safety and Efficacy of Repeated Administrations of NurOwn® in ALS PatientsBrainstorm-Cell Therapeutics · Amyotrophic Lateral Sclerosis (ALS)CompletedBCLILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 11, 2021ActualPhase 2NCT03799718Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MSBrainstorm-Cell Therapeutics · Multiple Sclerosis, Chronic ProgressiveCompletedBCLILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2012ActualPhase 1/Phase 2NCT01051882Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients.Brainstorm-Cell Therapeutics · Amyotrophic Lateral SclerosisCompletedBCLILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2014ActualPhase 2NCT01777646Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral...Brainstorm-Cell Therapeutics · Amyotrophic Lateral SclerosisCompletedBCLILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 7 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner